4//SEC Filing
Tade Brad L. 4
Accession 0001140361-24-034471
CIK 0001368514other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 9:05 PM ET
Size
8.4 KB
Accession
0001140361-24-034471
Insider Transaction Report
Form 4
Tade Brad L.
CFO and Treasurer
Transactions
- Award
Common Stock
2024-07-24+72,400→ 214,433 total - Award
Stock Option (right to buy)
2024-07-24+115,100→ 115,100 totalExercise: $13.58Exp: 2034-07-24→ Common Stock (115,100 underlying)
Footnotes (4)
- [F1]These shares represent restricted stock units ("RSUs") that will vest in four equal installments (25% per installment) on each annual anniversary of the date of grant over four years, in each case under the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the "Plan") subject to the reporting person's continued service as of the applicable vesting date.
- [F2]Includes, as of the transaction date, (i) 72,400 RSUs granted on July 24, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 75,000 unvested RSUs, granted by the Company on June 26, 2023, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting;
- [F3](Continued from Footnote 2 above) (iii) 50,000 RSUs, all of which are currently unvested, granted by the Company on February 26, 2024, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting; and (iv) 17,033 shares acquired in open market purchases and pursuant to the vesting of RSUs.
- [F4]The options vest over four years with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on the four-year anniversary of the grant date.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0002030561
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 9:05 PM ET
- Size
- 8.4 KB